Ending pediatric AIDS and achieving the Super-Fast-Track targets for pediatric HIV requires intensified efforts to rapidly identify and treat HIV-positive infants and young children. In 2017, only 51 percent of all HIV-exposed infants were tested for HIV within the recommended first two months of life, and only 52 percent of children living with HIV received lifesaving antiretroviral therapy (ART). Without access to timely diagnosis and treatment, up to 30 percent of HIV-infected children will die by their first birthday, and 50 percent will die by their second birthday.
Explore Related Resources
Resource
Research Review: Pediatric and Maternal HIV at AIDS 2026
Published September 2026
After reviewing the research on pediatric HIV presented at AIDS 2026, here is how we are putting these findings into practice.
View Resource
Topics:
Adolescents,
Children,
Maternal and Child Health,
Mothers and Infants,
Pediatric HIV,
Research
Countries:
Global
Issue Briefs
Common Ground for Global Health Policy Brief: Adolescent HIV
Published August 2026
This policy brief explains the current landscape of adolescent HIV, with a particular focus on adolescent girls and the barriers they face regarding prevention, diagnosis, and treatment. It also provides recommendations for U.S. policymakers.
View Resource
Topics:
Adolescents,
Advocacy,
HIV,
Pediatric HIV
Countries:
Global
Poster
Programmatic Gaps Under Option B+: Factors Associated with Residual Vertical HIV Transmission in Malawi, 2020 – 2024
Published August 2026
In our study, vertical transmission was strongly associated with lack of ART at delivery and unsuppressed maternal viral load.
View Resource
Topics:
Prevention of Mother-to-Child Transmission (PMTCT),
Research
Countries:
Malawi